What is the recommended intravenous dose and administration schedule for hydralazine 20 mg?

Hydralazine 20 mg IV Dosing

For intravenous hydralazine, administer an initial dose of 10 mg via slow IV infusion, with a maximum initial dose of 20 mg, and repeat every 4-6 hours as needed. 1, 2, 3, 1, 4, 5, 1, 4, 3

Dosing Algorithm

Initial Administration

• Start with 10 mg IV as a slow bolus injection
• Maximum initial dose: 20 mg 6
• Administer as a slow IV infusion directly into the vein 6
• Use immediately after opening the vial; do not add to infusion solutions 6

Repeat Dosing

• Repeat every 4-6 hours as needed if blood pressure remains elevated 1, 2
• Blood pressure begins to decrease within 10-30 minutes, with effects lasting 2-4 hours 1, 2, 3
• Average maximal decrease occurs in 10-80 minutes 6

Dose Adjustments

• Patients with marked renal damage may require lower doses 6
• Check blood pressure frequently after administration 6

Critical Limitations and Warnings

Hydralazine is NOT a desirable first-line agent for acute hypertensive treatment in most patients due to:

• Unpredictability of blood pressure response 1, 2, 3
• Prolonged duration of action (2-4 hours) 1, 2
• Less titratable compared to continuous infusion agents 1

Preferred Alternatives for Hypertensive Emergencies

The 2017 ACC/AHA guidelines recommend titratable continuous infusion agents as preferable options 1, 2:

• Nicardipine (initial 5 mg/h)
• Labetalol (0.3-1.0 mg/kg IV or continuous infusion)
• Clevidipine (initial 1-2 mg/h)

Specific Indications Where Hydralazine May Be Used

1. Severe hypertension in pregnancy/postpartum 7, 8

   • 5 mg IV or IM initially
   • Repeat 5-10 mg every 20-40 minutes
   • Maximum cumulative dose: 20 mg 7
   • Onset: 10-20 minutes 7

2. Second-line option when other agents contraindicated 8

3. Patients intolerant to ACE inhibitors/ARBs (in combination with nitrates for heart failure) 9

Common Pitfalls to Avoid

Do NOT Use Hydralazine When:

• Titratable agents are available - continuous infusion drugs allow better BP control 1
• Treating asymptomatic hypertension in hospitalized patients - associated with hypotension, acute kidney injury, and ICU transfers without improving outcomes 10, 11, 12
• Rapid, precise BP control is needed - response is unpredictable 1, 2

Safety Concerns

• Hypotension risk: 17% of patients experienced adverse events in one study, with hypotension being most common 10
• Reflex tachycardia: More common with hydralazine than labetalol 13
• Maternal tachycardia and palpitations: Significantly more frequent in pregnancy studies 13
• 69% of IV hydralazine use lacked appropriate indications in one hospital audit 11

Monitoring Requirements

• Check BP frequently after administration 6
• Monitor for reflex tachycardia 13
• In patients with increased intracranial pressure, lowering BP may increase cerebral ischemia 6

Transition to Oral Therapy

• Most patients can be transferred to oral hydralazine within 24-48 hours 6
• Transition once BP is stabilized and patient can tolerate oral medications

Product Handling

• Discard unused portion - single-dose vial 6
• Do not use discolored solutions - may discolor upon contact with metal 6
• Use immediately after opening 6